Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma

Clinical trial NCT03552380 · TERMINATED

Trial details

NCT number: NCT03552380
Sponsor: Roberto Pili
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2018-07-31
Primary completion: 2022-06-07
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.